On Wednesday, BioNTech SE (NASDAQ:BNTX) agreed to acquire Biotheus, a clinical-stage biotechnology company focused on ...

BioNTech (BNTX) and Biotheus announced the signing of a definitive agreement for the acquisition of Biotheus, a clinical-stage biotechnology company dedicated to the discovery and development of novel ...

Acquisition to support the global execution of BioNTech’s oncology strategy and provide full global rights to BNT327/PM8002, an investigational PD-L1 x VEGF-A bispecific antibody, with potential to ...

CHICAGO--GE HealthCare (Nasdaq: GEHC) has received FDA 510(k) clearance for its innovative SIGNA™ MAGNUS,i a 3.0T ...

Today, BioNTech revealed a definitive agreement to acquire China-based Biotheus, a clinical-stage biotechnology company ...

GE HealthCare (Nasdaq:GEHC) announced today that it received FDA 510(k) clearance for its Signa Magnus MRI scanner.

Procedures like partial nephrectomy for kidney cancer, endoscopic resection or partial cystectomy for bladder cancer, and ...

Marbella will once again be running its 2024 pink-themed solidarity race in order to raise awareness for the prevention and ...

The Italian tennis player in Turin for the ATP Finals promotes the initiative “An Ace for Research” by Intesa Sanpaolo and ...

It's still a couple of years away from achieving actual profitability, but it's taking steps in the right direction. Finally, ...

The rapid advancements in mRNA technology have opened new avenues for vaccine development, particularly in the prevention and treatment of infectious and oncological diseases. Lipid nanoparticles (LNP ...

Can-Fite BioPharma (CANF) Company Description: Can-Fite BioPharma Ltd. operates as a clinical-stage biopharmaceutical company, which focuses on developing orally bioavailable small molecule ...